Medermica Files Second Technology Patent

MEDERMICA FILES SECOND TECHNOLOGY PATENT

IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is pleased to announce that its portfolio company, Medermica Limited ("Medermica"), has filed a further patent application relating to its novel technology for the measurement of pH.

This patent application relates to the manufacturing processes for the devices. Specifically, new claims for the electrodes have been included that will very significantly reduce the costs of materials involved in the manufacturing process.

Medermica's innovative pH measurement technology is cheap, accurate, rapid and disposable. This valuable technology is relevant to a wide range of commercial, industrial and medical applications, which currently use traditional pH measuring techniques, including pharmaceutical manufacturing, food processing and research. An additional advantage is that it can measure the pH of very small volumes of samples (less than one microlitre).

Medermica has commenced licensing discussions with potential partners.

Peter Knox, Chairman of Medermica and a non executive director of IPSO, said: "Our technology has very wide applications and we are excited by the considerable potential market for such a device."

…Ends…

Further information, please contact:

NOTES TO EDITORS

IPSO:

IPSO creates commercial value from technology and its business model is entirely demand driven. It works closely with its industrial collaborators to identify the demand for new, innovative technologies and then, through its strong relationships with research institutions, sources technologies which could meet those needs. Much of this technology requires considerable further work by IPSO before it can be sold to industry as a developed product. IPSO creates businesses and provides expertise, strategic direction, human and seed capital, as well as corporate finance advice.

For industrial collaborators, IPSO provides a mechanism to identify and develop technologies which could be of significant value to their businesses and removes the risk to them of acquiring raw, unproven and undeveloped technology.

For research institutions, IPSO provides greater certainty that their technology will find commercial success.

Medermica

Medermica is a technology development company, focused on diagnostic and sensor technologies for laboratory or healthcare applications. It was created by IPSO in May 2006 to progress certain sensor technologies which have been developed by Dr Danny O'Hare, Reader in Sensor Research in the Department of Bioengineering at Imperial College. Imperial Innovations plc is a shareholder in Medermica.